Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival prEdiction in bLadder Cancer Patients Treated by nEoadjuvant Chemotherapy Before cysTectomy

NCT06294054 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT06294054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06294054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival prEdiction in bLadder Cancer Patients Treated by nEoadjuvant Chemotherapy Before cysTectomy
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2023
Completion date
March 31, 2026
Enrollment
707 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, genomic instability